loadpatents
name:-0.027459859848022
name:-0.016829967498779
name:-0.0011961460113525
Mack; Christine M. Patent Filings

Mack; Christine M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mack; Christine M..The latest application filed is for "hybrid polypeptides with selectable properties".

Company Profile
0.22.25
  • Mack; Christine M. - Camarillo CA
  • Mack; Christine M. - San Diego CA
  • Mack; Christine M. - Ventura CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hybrid polypeptides with selectable properties
Grant 9,453,063 - Levy , et al. September 27, 2
2016-09-27
GIP analog and hybrid polypeptides with selectable properties
Grant 9,133,260 - Levy , et al. September 15, 2
2015-09-15
GIP and exendin hybrid polypeptides
Grant 8,895,498 - Levy , et al. November 25, 2
2014-11-25
Amylin-calcitonin Chimeric Peptides Conjugated To Duration Enhancing Moieties
App 20140249076 - Samant; Manoj P. ;   et al.
2014-09-04
Hybrid Polypeptides With Selectable Properties
App 20140249299 - Levy; Odile Esther ;   et al.
2014-09-04
Methods for affecting body composition using amylin agonists
Grant 8,748,375 - Mack , et al. June 10, 2
2014-06-10
Hybrid polypeptides with selectable properties
Grant 8,697,647 - Levy , et al. April 15, 2
2014-04-15
Methods for treatment using amylin family peptides
Grant 8,598,120 - Soares , et al. December 3, 2
2013-12-03
Dpp-iv Resistant Gip Hybrid Polypeptides With Selectable Properties
App 20130281374 - Levy; Odile Esther ;   et al.
2013-10-24
Compositions and Methods for the Control, Prevention and Treatment of Obesity and Eating Disorders
App 20130225485 - Weyer; Christian ;   et al.
2013-08-29
Gip Analog And Hybrid Polypeptides With Selectable Properties
App 20130196913 - Levy; Odile Esther ;   et al.
2013-08-01
DPP-IV resistant GIP hybrid polypeptides with selectable properties
Grant 8,497,240 - Levy , et al. July 30, 2
2013-07-30
Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
App 20130184213 - LAUGERO; Kevin D. ;   et al.
2013-07-18
Gip Analog And Hybrid Polypeptides With Selectable Properties
App 20130137631 - LEVY; Odile Esther ;   et al.
2013-05-30
GIP analog and hybrid polypeptides with selectable properties
Grant 8,404,637 - Levy , et al. March 26, 2
2013-03-26
Amylin and amylin agonists for treating psychiatric diseases and disorders
Grant 8,389,477 - Laugero , et al. March 5, 2
2013-03-05
Neuromedin and FN-38 Peptides for Psychotic Diseases
App 20130035294 - Laugero; Kevin D. ;   et al.
2013-02-07
Neuromedin and FN-38 peptides for treating psychiatric diseases
Grant 8,309,522 - Laugero , et al. November 13, 2
2012-11-13
Hybrid Polypeptides With Selectable Properties
App 20120253023 - LEVY; Odile Esther ;   et al.
2012-10-04
Method of modifying food preference comprising administering amylin or amylin agonist
Grant 8,278,267 - Weyer , et al. October 2, 2
2012-10-02
GIP analog and hybrid polypeptides with selectable properties
Grant 8,263,545 - Levy , et al. September 11, 2
2012-09-11
Methods For Affecting Body Composition Using Amylin Agonists
App 20120053118 - Mack; Christine M. ;   et al.
2012-03-01
Hybrid polypeptides having glucose lowering activity
Grant 8,076,288 - Levy , et al. December 13, 2
2011-12-13
Amylin And Amylin Agonists For Treating Psychiatric Diseases And Disorders
App 20110288028 - Laugero; Kevin D. ;   et al.
2011-11-24
Compositions And Methods For The Control, Prevention And Treatment Of Obesity And Eating Disorders
App 20110263491 - WEYER; Christian ;   et al.
2011-10-27
DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties
App 20110136737 - Levy; Odile Esther ;   et al.
2011-06-09
Methods for controlling binge eating disorders
Grant 7,879,794 - Weyer , et al. February 1, 2
2011-02-01
Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
App 20100125054 - Laugero; Kevin D. ;   et al.
2010-05-20
Amylin agonist for treating depression, anxiety disorder and schizophrenia
Grant 7,671,023 - Laugero , et al. March 2, 2
2010-03-02
Hybrid Polypeptides with Selectable Properties
App 20090286723 - Levy; Odile Esther ;   et al.
2009-11-19
Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
App 20090181890 - Laugero; Kevin D. ;   et al.
2009-07-16
Compositions And Methods For The Control, Prevention And Treatment Of Obesity And Eating Disorders
App 20090062193 - Weyer; Christian ;   et al.
2009-03-05
Gip Analog And Hybrid Polypeptides With Selectable Properties
App 20090036364 - Levy; Odile Esther ;   et al.
2009-02-05
Gip Analog And Hybrid Polypeptides With Selectable Properties
App 20080312157 - Levy; Odile Esther ;   et al.
2008-12-18
Amylin and Amylin Agonists For Treating Psychiatric Diseases and Disorders
App 20080287355 - Laugero; Kevin D. ;   et al.
2008-11-20
Hybrid polypeptides with selectable properties
App 20060293232 - Levy; Odile Esther ;   et al.
2006-12-28
Hybrid polypeptides with selectable properties
App 20060094652 - Levy; Odile Esther ;   et al.
2006-05-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed